Stipend and Dates

Up to $5,125.

Dates are tentative and may change. Cohort 1a Cohort 1b Cohort 2a Cohort 2b
Day -1 Admit, start Holter monitoring stat Oct 09, 2023 Oct 12, 2023 Oct 16, 2023 Oct 19, 2023
Day 5 Discharge, stop Holter monitoring Oct 14, 2023 Oct 17, 2023 Oct 21, 2023 Oct 24, 2023
Day 7 Outpatient visit Oct 16 Oct 19 Oct 23 Oct 26
Day 10 Outpatient visit Oct 19 Oct 22 Oct 26 Oct 29
Day 17 Outpatient visit Oct 26 Oct 29 Nov 02 Nov 05
Day 22 Followup Outpatient visit Oct 31 Nov 03 Nov 07 Nov 10

 

Click here to make an appointment for NO 0009-0825

Or call 210-225-5437 for more information

 

Study Criteria

Healthy non-smoking overweight Males and Females

Age:  18-55

BMI:  27.0 to 39.9 kg/m2

 

Study Information

Indication: The investigational drug is being developed as a possible treatment of weight management.

Route of Administration: Subcutaneous

Washout from previous study: You may not participate in any other clinical study within 30 days before receiving study drug in this study.

Male participants should use a condom during treatment and until the end of the study.

Female participants of childbearing potential are eligible to participate if they agree to use methods of contraception consistently and correctly. Highly effective contraception should be utilized until the end of study.

Highly effective contraceptive methods allowed:

  • Combined (estrogen- and progestogen-containing) hormonal contraception associated with inhibition of ovulation. Male condoms must be used in addition to hormonal contraception during the treatment period and until the end of study.
    • Oral
    • Intravaginal
    • Transdermal
  • Progestogen-only contraception associated with inhibition of ovulation
    • Oral
    • Injectable
    • Implantable
  • Intrauterine device (IUD)
  • Intrauterine hormone-releasing system (IUS)
  • Bilateral tubal occlusion, or bilateral tubal ligation
  • Vasectomized partner
  • Sexual abstinence (Preferred and usual lifestyle)

Study Reminders

  • 8 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
  • Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a valid government issued identification card such as a driver's license, state issued ID card or passport.  You will be required to show this same photo ID at all study visits
  • Arrive 30 minutes before your appointment to complete paper work.
Reference
NO 0009-0825
Name
Healthy Overweight Males and Females
Gender
Male or Female
Payment amount
Up to $5,125
Age
18 - 55